UK adds nerve disorder as rare side-effect of AstraZeneca COVID-19 vaccine

Medicines and Healthcare products Regulatory Agency’s (MHRA) decision comes after the European Medicines Agency (EMA) added GBS as a possible side-effect last month
Read Article

The UK drug regulator added an extremely rare nerve-damaging disorder, Guillain-Barré syndrome (GBS), as a very rare side effect of the AstraZeneca COVID-19 vaccine, updates on the agency’s website showed yesterday.

Medicines and Healthcare products Regulatory Agency’s (MHRA) decision comes after the European medicines agency added GBS as a possible side-effect last month.

AstraZenecaAstraZeneca COVID vaccineEMAGuillain-Barre´ syndromeMHRA
Comments (0)
Add Comment